Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full...
Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full...
HASSELT, BELGIUM & BOSTON, MA, US – 28/09/18 | UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artif...
Hasselt, Belgium & Boston, Massachusetts - UgenTec, a software company focusing on simplifying and automating real-time qPCR diagnostics, today ann...
We're excited to announce today our partnership with Serosep Ltd., a leading global manufacturer of molecular solutions for clinical laboratories....
We're excited to announce our brand new initiative in molecular diagnostics: the Molecular Automation Network. This network is a consortium of comp...
We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 mi...
HERSTAL & HASSELT, BELGIUM – 23/01/18 | UgenTec, an innovative European medical device software company that develops artificially intelligent PCR ...
Hasselt, Belgium, December 19, 2017. | Steven Verhoeven, previously Agilent’s head of genomics software, will join UgenTec to take up the role of c...
LUXEMBOURG, LUXEMBOURG & HASSELT, BELGIUM – 05/12/17 | Fast Track Diagnostics S.à.r.l., one of the leading global suppliers of syndromic real-time ...
DARMSTADT, GERMANY and HASSELT, BELGIUM, September 21st, 2017 – R-Biopharm AG announced today it has entered into an agreement with UgenTec to coll...
With FastFinder 3.0, we've taken another step towards full PCR automation. In this blogpost, you'll find a list of the most important features and ...
BRUSSELS, BELGIUM and HASSELT, BELGIUM—. UgenTec, the Belgian PCR automation software company is approved for the SME Instrument Phase 1 by the Eur...
UgenTec, the Belgian PCR automation software company and Hamann Laborautomation today announced their partnership venture into the PCR middleware l...
Founded in 2009 in Sydney, SpeeDx’ current IVD portfolio consists of two multiplex assays: ResistancePlus™ MG and PlexPCR™ HSV-1&2, VZV. The compa...
UgenTec & PathoFinder have successfully rolled out the interpretation solution for PathoFinder’s next generation multiplex PCR 2SMART assays.
UgenTec NV, the European bio-informatics company that develops artificially intelligent PCR interpretation software, and SpeeDx Pty. Ltd., a develo...
UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €...
UgenTec has been nominated for the 2016 Rising Star award, together with nine other innovative and rapid growing companies. The Rising Star selecti...
Today, we can announce that our team has successfully passed the audit for the ISO 13485:2012 Medical Devices. You can check our official certifica...
We're happy to announce that Unizo, the organization that represents employers and entrepreneurs in Flanders, has elected UgenTec to be the "Most P...
We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 00...
We are proud to announce that we've won the “Flanders Future” award. The award is handed to companies that are deemed the most capable of achieving...
UgenTec’s FastFinder has won the “Healthcare idea award 2014” for the most innovative product in healthcare. The software, developed by UgenTec, al...
